Alcoholism is responsible for one third of preventible loss of life in the United States. About 50-60% of the predisposition to develop alcoholism is genetically determined, and both permissive and protective genes have been identified. Two gene variants strongly associated with protection against alcohol abuse and alcoholism modify the metabolism of ethanol. These genes code for enzymes that either increase the production or reduce the elimination of acetaldehyde, the first product of ethanol metabolism. A dominant negative allele of aldehyde dehydrogenase (ALDH2) found in East Asians codes for an inactive ALDH2*2 that does not metabolize acetaldehyde efficiently. This results in increased levels of circulating acetaldehyde and in an aversive reaction that protects against alcoholism by 65 to 95%. Another protective gene variant ADHIB*2 codes for an alcohol dehydrogenase with a high activity in oxidizing ethanol into acetaldehyde. This inborn protection against alcoholism can reach 50-60%. Disulfiram, an ALDH inhibitor used in the treatment of alcoholism has two main drawbacks that have reduced its use; marked toxicity due to nonspecific action and poor patient compliance with daily intake. Studies in this application test the hypothesis that a reduction ofALDH2 gene expression or ADH gene transduction decrease voluntary ethanol intake in rats, thus mimicking the natural protective mechanisms. The hypothesis will be tested initially in vitro in rat hepatoma cells and further evaluated in vivo in rats. The protective mechanism afforded by a low ALDH2 activity will be elicited by (i) orally-absorbable third generation antisense morpholino oligonucleotides directed against ALDH2 mRNA, and (ii) short interference RNAi molecules blocking ALDH2 mRNA administered with long-lasting adenoviral vectors. The high-activity ADH protective mechanism will be mimicked by (iii) transduction of the human ADHIB*2 gene and overexpression of the rat Adh with adenoviral vectors. As a 'proof of principle' we will (iv) determine the ability of single-point mismatched oligodeoxynucleotides to generate the Glu486Lys dominant-negative point mutation of ALDH2*2 in human hepatoma cells that carry the ADH gene, thus generating new cell lines that produce high levels of acetaldehyde. Overall, the proposed studies aim at inducing gene-based protective mechanisms that are specific and could be used for the treatment of alcoholism.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA015421-02
Application #
7125618
Study Section
Xenobiotic and Nutrient Disposition and Action Study Section (XNDA)
Program Officer
Gentry, Thomas
Project Start
2005-09-30
Project End
2010-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
2
Fiscal Year
2006
Total Cost
$304,369
Indirect Cost
Name
Thomas Jefferson University
Department
Pathology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Rivera-Meza, Mario; Quintanilla, MarĂ­a Elena; Tampier, Lutske (2012) Reduction of ethanol consumption in alcohol-preferring rats by dual expression gene transfer. Alcohol Alcohol 47:102-8
Quintanilla, Maria E; Tampier, Lutske; Karahanian, Eduardo et al. (2012) Reward and relapse: complete gene-induced dissociation in an animal model of alcohol dependence. Alcohol Clin Exp Res 36:517-22
Guan, Xiangying; Rubin, Emanuel; Anni, Helen (2012) An optimized method for the measurement of acetaldehyde by high-performance liquid chromatography. Alcohol Clin Exp Res 36:398-405
Israel, Yedy; Rivera-Meza, Mario; Quintanilla, Maria Elena et al. (2011) Acetaldehyde burst protection of ADH1B*2 against alcoholism: an additional hormesis protection against esophageal cancers following alcohol consumption? Alcohol Clin Exp Res 35:806-10
Karahanian, Eduardo; Quintanilla, Maria Elena; Tampier, Lutske et al. (2011) Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res 35:606-12
Rivera-Meza, Mario; Quintanilla, Maria Elena; Tampier, Lutske et al. (2010) Mechanism of protection against alcoholism by an alcohol dehydrogenase polymorphism: development of an animal model. FASEB J 24:266-74
Arolfo, Maria P; Overstreet, David H; Yao, Lina et al. (2009) Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res 33:1935-44
Bustamante, Diego; Quintanilla, Maria Elena; Tampier, Lutske et al. (2008) Ethanol induces stronger dopamine release in nucleus accumbens (shell) of alcohol-preferring (bibulous) than in alcohol-avoiding (abstainer) rats. Eur J Pharmacol 591:153-8
Igoucheva, Olga; Alexeev, Vitali; Anni, Helen et al. (2008) Oligonucleotide-mediated gene targeting in human hepatocytes: implications of mismatch repair. Oligonucleotides 18:111-22
Israel, Yedy; Quintanilla, Maria E; Sapag, Amalia et al. (2006) Combined effects of aldehyde dehydrogenase variants and maternal mitochondrial genes on alcohol consumption. Alcohol Res Health 29:281-5